NetworkNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) C
Post# of 111
(Total Views: 219)
Posted On: 04/25/2023 4:04:37 PM
NetworkNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Closes on $1.9M Registered Direct Offering
Aditxt (NASDAQ: ADTX), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, announced that it has closed on its previously announced registered direct offering. The company transacted the closing with a single healthcare-focused institutional investor; the closing consisted of the purchase and sale of 1,585,350 shares of common stock (or common stock equivalents in lieu thereof), which were made available at a purchase price of $1.22 per share. In addition, the company also transacted a concurrent private placement, which included the issuance of unregistered warrants to purchase up to 3,170,700 shares of common stock; those shares had an exercise price of $0.86 per share and are immediately exercisable for a period of three years following issuance. The company noted that H.C. Wainwright & Co. acted as the exclusive placement agent for the offering, which resulted in gross proceeds of an estimated $1.9 million. According to the announcement, the company anticipates using the funds for working capital and other general corporate purposes.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Aditxt (NASDAQ: ADTX), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, announced that it has closed on its previously announced registered direct offering. The company transacted the closing with a single healthcare-focused institutional investor; the closing consisted of the purchase and sale of 1,585,350 shares of common stock (or common stock equivalents in lieu thereof), which were made available at a purchase price of $1.22 per share. In addition, the company also transacted a concurrent private placement, which included the issuance of unregistered warrants to purchase up to 3,170,700 shares of common stock; those shares had an exercise price of $0.86 per share and are immediately exercisable for a period of three years following issuance. The company noted that H.C. Wainwright & Co. acted as the exclusive placement agent for the offering, which resulted in gross proceeds of an estimated $1.9 million. According to the announcement, the company anticipates using the funds for working capital and other general corporate purposes.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)ADiTx Therapeutics Inc. (ADTX) Stock Research Links
Scroll down for more posts ▼